Sirt1 and Sirt6 Mediate Beneficial Effects of Rosiglitazone on Hepatic Lipid Accumulation
Soo Jin Yang(Chonnam National University), Cheol-Young Park(Kangbuk Samsung Hospital)
Cited by 24
Related Papers
Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats
|PLoS ONE|2011|78
Supplementation with Nicotinamide Riboside Reduces Brain Inflammation and Improves Cognitive Function in Diabetic Mice
|International Journal of Molecular Sciences|2019|48
Nicotinamide riboside regulates inflammation and mitochondrial markers in AML12 hepatocytes
|Nutrition Research and Practice|2019|29